This is critical. If we're going to try and treat pre-RA, it's all about picking the right patient: - avoid exposing future non-responders to harm - modify the course of disease in those who will benefit Fantastic that @eular_org are addressing this need. #EULAR2024 @RheumNow https://t.co/9pF33eLbuZ